According to our latest research, the global anti-inflammatory peptides market size reached USD 1.63 billion in 2024, driven by increasing interest in novel therapeutic agents and the growing prevalence of chronic inflammatory diseases. The market is demonstrating robust momentum, registering a CAGR of 8.7% from 2025 to 2033. By the end of 2033, the anti-inflammatory peptides market is forecast to attain a value of approximately USD 3.43 billion. This growth is primarily attributed to heightened R&D investments, a rising geriatric population, and the expanding application of peptides across pharmaceuticals, nutraceuticals, and cosmetics sectors. https://growthmarketreports.com/report/anti-inflammatory-peptides-market-global-industry-analysis